Sharyl Nass, Ph.D., is a study director and senior program officer at the IOM, where she has worked with the Board on Health Sciences Policy, the Board on Health Care Services, and the National Cancer Policy Board and Forum. She was also recently named as the director of the IOM’s National Cancer Policy Forum. Her previous work at the IOM has focused on topics that include developing cancer biomarkers, formulating strategies for large-scale biomedical science, developing technologies for the early detection of breast cancer, improving breast imaging quality standards, improving the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, and facilitating contraceptive research and development. Her current IOM position combines her dual interests in biomedical research and health science policy. With a Ph.D. in Cell and Tumor Biology from Georgetown University and postdoctoral training at the Johns Hopkins University School of Medicine, she has authored numerous papers on the cell and molecular biology of breast cancer. She also holds a B.S. in Genetics and an M.S. in Endocrinology/Reproductive Physiology, both from the University of Wisconsin–Madison. In addition, she studied developmental genetics and molecular biology at the Max Planck Institute in Germany under a fellowship from Fulbright and the German Heinrich Hertz-Stiftung Foundation. Dr. Nass was the 2007 recipient of the IOM’s Cecil Award for Excellence in Health Policy Research.

Erin Balogh, M.P.H., joined the IOM in 2008 as a research associate for the NCPF and Board on Health Care Services. She is currently working on two committee studies, the Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease and Cancer Clinical Trials and the NCI Cooperative Group Program. She completed her M.P.H. at the University of Michigan in Health Management and Policy, and prior to that, graduated summa cum laude from Arizona State University with her Bachelor’s Degrees in Microbiology and Psychology. Ms. Balogh interned with AcademyHealth in Washington, DC, and worked as a research site coordinator for the Urban Institute in Topeka, Kansas. As an undergraduate, Ms. Balogh worked as a management intern with the Arizona State University Office of University Initiatives, a strategic planning group for the university.

Bernadette McFadden, M.Sc., joined the IOM as a research associate in 2008. Since that time, she has staffed projects on the redesign of continuing education for health professionals and the standardization of race, ethnicity, and language data. She currently works with the Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease and the Committee on Future Directions for the National Healthcare

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement